PL EN


Preferences help
enabled [disable] Abstract
Number of results
2020 | 74(4) | 37-40
Article title

Nasal Mucormycosis: Our experience with 24 cases

Content
Title variants
Languages of publication
Abstracts
EN
Background: Mucormycosis is a rare fungal infection affecting people with impaired immunity. The aim of this study is to shed light on the epidemiology, incidence, and outcome of patients with mucormycosis hospitalized at a tertiary care center in Pondicherry.
Methods: We conducted a retrospective chart review between January 2008 and January 2018. All patients with proven or probable mucormycosis were included.
Results: A total of 24 patients were included. Their median age was 49 years and the majority were males. Comorbidities included mainly hematologic malignancy and diabetes mellitus. A liposomal amphotericin B formulation alone or in combination with other antifungals was used as a first line agent in all patients.
Conclusion: The incidence of mucormycosis has significantly increased over the past 10 years at our institution, most likely due to increased risk factors.
Year
Volume
Pages
37-40
Physical description
Dates
published
2020-02-20
References
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.ceon.element-13ecf6ce-30fa-3912-8c81-f428366399f1
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.